Skip to content

13F-HR filed by Melqart Asset Management (UK) Ltd

Melqart Asset Management (UK) Ltd filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-11, with 16 holding rows worth $831,980,000.

Accession
0001172661-18-001034
Filed
2018-05-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 16 entries on the cover page, a total value of $831,980,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $831,980,000 with VALUE read as thousands by filing date, 13F file number 028-18520. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NXP SEMICONDUCTORS N V COMN6596X109Stock1,646,185$192,604,000thousands by filing date
MONSANTO CO NEW61166W101COM1,102,000$128,592,000thousands by filing date
TIME WARNER INC887317303COM NEW1,113,698$104,890,000thousands by filing date
QIWI PLC74735M108SPON ADR REP B3,218,878$61,513,000thousands by filing date
Qualcomm Incorporated747525103COM786,500$43,580,000thousands by filing date
XL GROUP LTDG98294104COM773,749$42,757,000thousands by filing date
ATLANTICA YIELD PLCG0751N103SHS2,020,794$39,567,000thousands by filing date
DELL TECHNOLOGIES INC CLASS CLASS C24703L103CLASS C433,997$31,773,000thousands by filing date
QUINTANA ENERGY SVCS INC74875T103COM3,128,555$30,503,000thousands by filing date
EQT CORP COM26884L109Stock634,000$30,121,000thousands by filing date
AKORN INC009728106COM1,387,688$25,964,000thousands by filing date
NXP SEMICONDUCTORS N V COMN6596X109Stock186,700$21,844,000thousands by filing datecall
WORLDPAY INC981558109CL A256,000$21,053,000thousands by filing date
MONSANTO CO NEW61166W101COM175,000$20,421,000thousands by filing datecall
DIEBOLD NXDF INC253651103COM1,198,241$18,453,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM298,200$18,345,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-18-001034this filing2018-05-11acceptance time not in the bulk data set